Skip to content

Bioalmanac

Wolverine

Wolverine blend · BPC TB blend · BPC-157 TB-500 blend

Preclinical

Status reviewed 25 Aug 2026

Prohibited in sport

BPC-157 and TB-500 in one vial at 1:1. The oldest and simplest of the named blends, and the only one without a settled vial size.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes both components with it.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Reconstitution — 20 mg vial, 500 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL20 mg/mL0.025 mL2.5 units40
2 mL10 mg/mL0.05 mL5 units40
3 mL6.667 mg/mL0.075 mL7.5 units40
5 mL4 mg/mL0.125 mL12.5 units40

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Commonly described community protocol500–1000 mcgDaily, in courses of 4 to 8 weeksCommunity practice

When to stop

  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
  • An injection site that becomes hot, spreading or produces pus.
  • Any new or changing lump. Both components are associated with proliferation in animal models.

Not approved anywhere as a mixture or as either of its parts. Sold as a research chemical, in at least two vial sizes under the same name.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/wolverine

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.